Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
Scientific Community
Become a Member | Sign in
Home>News>This Article

Scripps Research Appoints Cancer Biologist

Published: Monday, August 06, 2012
Last Updated: Monday, August 06, 2012
Bookmark and Share
Christoph Rader is appointed as associate professor in the Department of Cancer Biology and the Department of Molecular Therapeutics.

Before coming to Scripps Florida, Rader was a senior scientist at the National Cancer Institute (NCI) in Bethesda, Maryland. Prior to that, he was an assistant professor on the La Jolla, California, campus of Scripps Research.

“We want to welcome Christoph back to Scripps Research,” said John L. Cleveland, chair of the Scripps Research Department of Cancer Biology. “In California, his groundbreaking antibody research helped pioneer a hybrid cancer therapy, and at NIH he was responsible for developing several innovative approaches to antibody drug and target discovery. He’s a great addition to our department and to the institute as a whole.”

“It’s a great pleasure to return to Scripps Research—and to be part of Scripps Florida,” said Rader, 46, who lives with his wife and two sons in Jupiter. “The faculty here is terrific, not only in cancer biology, but also in molecular therapeutics and chemistry. What I missed most at the NCI was being able to work more closely with chemists—they were 45 minutes away. Now, chemists are minutes from my office.”

Rader has already taken advantage of that proximity, launching collaborations with Scripps Florida chemists William R. Roush and Thomas Kodadek.

Rader’s research is focused on developing antibody therapies to treat cancer. “Monoclonal antibody therapy of cancer is a tremendously exciting and rewarding field that thrives on multidisciplinary expertise in biology, biochemistry, chemistry, pharmacology, and medicine,” said Rader. “Prompted by current knowledge, we have gone back to the drawing board to design, engineer, test, and deliver the next generation of monoclonal antibodies that target cancer cells with even higher precision and potency. Scripps Florida is an ideal place for hanging our drawing board and developing novel technologies at the interface of chemistry and biology.”

Rader studied biochemistry and molecular biology at the University of Bayreuth in Germany (1986-1988) and at the University of Zurich in Switzerland (1988-1995), where he graduated with a diploma in biochemistry in 1991. In 1995, he was awarded a PhD with honors from the University of Zurich for his work on immunoglobulin superfamily molecules.

Rader did postdoctoral work with Professor Carlos F. Barbas III at Scripps California, where he specialized in antibody engineering, phage display, and catalytic antibody technologies. Following his promotion to assistant professor at Scripps Research in 1999, he won the prestigious Investigator Award from the Cancer Research Institute in 2000. Shortly after, he was part of a Scripps Research team that invented the concept of chemical programming of monoclonal antibodies to generate hybrid cancer therapeutics, a cross between traditional small molecules and a certain type of monoclonal antibody. After commercialization, this innovation has brought several new drugs into phase I and II clinical trials for the treatment of various cancers and metabolic diseases.

Rader joined the NCI in 2003 to head the Antibody Technology Section in the Experimental

Transplantation and Immunology Branch. In 2007, he received the NCI Director's Intramural Innovation Award for Principal Investigators for a novel chemical programming concept. His achievements include more than 80 publications and 13 patents or patent applications in the area of antibody engineering and conjugation technologies.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Team Led by Scripps Research Scientists Develops Technique to Determine Ethnic Origin of Stem Cell Lines
Cells more representative of U.S. and world population could lead to more accurate research and safer, effective therapites.
Monday, January 04, 2010
Small RNAs may Play Big Role in Embryonic Stem Cells
A new study led by Scripps researchers could increase understanding of stem cells and advance development of potential therapies.
Saturday, April 12, 2008
Scripps Research Awarded $17M for Adult Stem Cell Use to Treat Eye Diseases
The Scripps Researchers will use the grant to develop treatment for patients who are losing their sight due to neovascular and retinal degenerative diseases.
Thursday, May 31, 2007
New Study Reveals Signaling Pathways Required for Expansion of Pancreas Stem Cells
A team of scientists has published a new study of important signaling pathways that are required for the expansion of pancreas stem cells.
Wednesday, May 17, 2006
Scientific News
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
Restoring Vision with Stem Cells
Age-related macular degeneration (AMRD) could be treated by transplanting photoreceptors produced by the directed differentiation of stem cells, thanks to findings published today by Professor Gilbert Bernier of the University of Montreal and its affiliated Maisonneuve-Rosemont Hospital.
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Tissue-Engineered Colon from Human Cells
A study by scientists at Children’s Hospital Los Angeles has shown that tissue-engineered colon derived from human cells is able to develop the many specialized nerves required for function, mimicking the neuronal population found in native colon.
Tension Helps Heart Cells Develop Normally in the Lab
Stanford engineers have uncovered the important role tension plays in growing heart cells out of the body.
Urine Excretion From Stem Cell-Derived Kidneys
Researchers report a strategy for enabling urine excretion from kidneys grown from stem cells.
Stem Cell Research Hints at Evolution of Human Brain
Researchers at UC San Francisco have succeeded in mapping the genetic signature of a unique group of stem cells in the human brain that seem to generate most of the neurons in our massive cerebral cortex.
The Final Word on STAP
Researchers fail to replicate STAP study; computational analysis reveals genomic inconsistency.
CRI Scientists See Through Bones
Findings uncover new details about blood-forming stem cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos